Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | IL-1 alpha | 100 | ng/mL | 4 | IL-8 | 12803.0 | 39 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | IL-8 | 335.5 | 34 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | IL-8 | 7515.0 | 36 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | IL-8 | 728.5 | 34 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | IL-8 | 1418.0 | 38 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | IL-8 | 647.0 | 31 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | IL-8 | 9045.0 | 28 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | IL-8 | 11772.5 | 36 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | IL-8 | 12818.0 | 27 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | IL-8 | 11805.0 | 33 | |
N2645 | TNF-a | 100 | ng/mL | 4 | IL-8 | 11570.0 | 25 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | IL-8 | 10769.0 | 24 | |
RA2708 | TNF-a | 100 | ng/mL | 4 | IL-8 | 10978.0 | 33 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | IL-8 | 72.0 | 19 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | IL-8 | 120.0 | 36 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | IL-8 | 97.0 | 32 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | IL-8 | 64.0 | 23 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 4 | IL-8 | 286.5 | 32 | ||||
RA2708 | IKK16 | 2.0 | uM | 4 | IL-8 | 629.5 | 22 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 4 | IL-8 | 158.0 | 27 | ||||
RA2159 | 4 | IL-8 | 172.5 | 20 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 4 | IL-8 | 159.0 | 29 | ||||
N2645 | 4 | IL-8 | 137.5 | 26 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | IL-8 | 444.5 | 34 | ||||
RA2708 | 4 | IL-8 | 752.0 | 20 |